Egypt Launches Technology Transfer Phase for Local PCV13 Vaccine Production

Egypt has launched the implementation phase of a technology transfer initiative to manufacture the pneumococcal vaccine PCV13 locally, in a step the Egyptian Drug Authority says will strengthen domestic production.

Dr. Tamer El-Husseiny, deputy chairman of the authority, attended the launch on behalf of its chairman, Dr. Ali El-Ghamrawy.

The initiative focuses on transferring the technology needed to manufacture PCV13, placing production know-how at the centre of efforts to localise vaccine manufacturing.

The authority framed the move as support for the localisation of Egypt’s pharmaceutical industry. The launch marks the start of the initiative’s implementation phase, rather than an announcement that local vaccine production has begun.